Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Candidemia and systemic candidiasis.

J D Sobel1, J Vazquez

  • 1Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan.

Seminars in Respiratory Infections
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated microscopy and pH test for diagnosis of vaginitis - the end of empiricism?

NPJ digital medicine·2023
Same author

Resistance to Fluconazole of Candida albicans in Vaginal Isolates: a 10-Year Study in a Clinical Referral Center.

Antimicrobial agents and chemotherapy·2023
Same author

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo-controlled superiority study (VANISH 306).

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Recurrent bacterial vaginosis, relapse or reinfection: the role of sexual transmission.

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure.

Current infectious disease reports·2019
Same author

Candida parapsilosis Vaginal Infection-a New Site of Azole Drug Resistance.

Current infectious disease reports·2018

Candidemia and systemic candidiasis are increasing due to more at-risk patients. Early diagnosis and new antifungal treatments like azoles offer improved management for invasive Candida infections.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Rising incidence of candidemia and systemic candidiasis linked to increased immunocompromised patient populations.
  • Candida species, opportunistic pathogens, exploit medical advancements for tissue invasion.
  • Emergence of novel clinical syndromes such as focal hepatosplenic candidiasis and Candida peritonitis.

Purpose of the Study:

  • To review the challenges and advancements in managing invasive candidiasis.
  • To highlight the diagnostic limitations in early detection of fungemia and tissue invasion.
  • To discuss current and emerging therapeutic strategies for Candida infections.

Main Methods:

  • Literature review of recent studies on candidemia and systemic candidiasis.

Related Experiment Videos

  • Analysis of clinical syndromes and host immune status influence.
  • Evaluation of diagnostic methods and antifungal treatment efficacy.

    • Main Results:

    • Invasive candidiasis presents diverse clinical syndromes influenced by host immunity.
    • Lack of reliable diagnostic tools hinders early detection of fungemia and tissue invasion.
    • Amphotericin B remains a primary treatment; newer oral azoles show promise.

    Conclusions:

    • Effective management of invasive candidiasis requires improved diagnostic capabilities.
    • Therapeutic strategies are evolving, with shorter regimens and newer azoles offering alternatives.
    • Understanding host-pathogen interactions is crucial for combating Candida infections.